Biotech company Amgen is buying Onyx Pharmaceuticals, the companies said Sunday.
The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.
Bayer HealthCare and Onyx Pharmaceuticals are seeking approval for a new drug to treat tumors of the gut, the companies said.
The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.
Onyx Pharmaceuticals has appointed a new SVP global corporate affairs.
The Food and Drug Administration has granted priority review for an investigational cancer treatment created by Bayer and Onyx Pharmaceuticals.
Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.
An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.
A new three-drug combination may work as a front-line treatment for cancer of the plasma cells, according to an early-stage clinical study.
A drug made by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals failed to extend overall survival...